Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
EYEG Stock Forecast 2026-2027
$35.63
Current Price
$0
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to EYEG Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
EYEG Price Momentum
+0.7%
1 Week Change
+0.9%
1 Month Change
+2.5%
1 Year Change
-0.4%
Year-to-Date Change
-2.7%
From 52W High of $36.63
+3.2%
From 52W Low of $34.52
📊 TOP ANALYST CALLS
Did EYEG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if EyeGate is one of their latest high-conviction picks.
Latest EYEG Stock Price Targets & Analyst Predictions
EYEG has shown a year-to-date change of -0.4% and a 1-year change of 2.5%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for EYEG. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EYEG Analyst Ratings
3
Buy
0
Hold
0
Sell
EYEG Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $35.63
Latest EYEG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EYEG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 16, 2021 | HC Wainwright & Co. | Yi Chen | Buy | Maintains | $11.00 |
| Nov 12, 2020 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Jul 21, 2020 | Alliance Global Partners | Buy | Initiates | $N/A | |
| May 19, 2020 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 15, 2017 | H.C. Wainwright | Buy | Maintains | $N/A | |
| Apr 7, 2016 | Noble Financial | Buy | Initiates | $N/A |
AB Corporate Bond ETF (EYEG) Competitors
The following stocks are similar to EyeGate based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AB Corporate Bond ETF (EYEG) Financial Data
Valuation Metrics
Market Cap
$0
Enterprise Value
$-823,559
P/E Ratio
-20.1x
PEG Ratio
N/A
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
EPS Growth
N/A
Financial Health
Cash/Price Ratio
N/A
Current Ratio
20.2x
Debt/Equity
0.0x
ROE
+7.5%
ROA
-577.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
AB Corporate Bond ETF (EYEG) Business Model
About AB Corporate Bond ETF
What They Do
Actively managed ETF focusing on corporate bonds.
Business Model
The fund generates income and capital appreciation by investing at least 80% of its net assets in investment-grade corporate bonds. It employs a dynamic, multifactor investment strategy to achieve excess returns compared to its benchmark while managing risk.
Additional Information
The ETF is diversified across various sectors and maturities, with a minor portion allocated to below-investment-grade debt. Managed by AllianceBernstein, it offers monthly dividend distributions, appealing to investors prioritizing income and capital preservation.
AB Corporate Bond ETF (EYEG) Latest News & Analysis
Latest News
Bonds still bouncing along
1 year ago
Quick Summary
Bond prices are fluctuating, indicating ongoing volatility in the bond market. Investors should monitor these movements for potential investment opportunities.
Why It Matters
Stable bond performance indicates low volatility and consistent yield, suggesting a favorable environment for fixed-income investments and potential shifts in interest rate expectations.
Source: CNBC Television
Market Sentiment:
Neutral
AllianceBernstein Launches 5 New Active ETFs
2 years ago
Quick Summary
AllianceBernstein has launched five active ETFs, two on the NYSE and three on Nasdaq, following a milestone of over $1 billion in active ETF assets under management.
Why It Matters
AllianceBernstein's launch of five active ETFs signals growth and diversification in their product line, potentially attracting more investor capital and increasing competition in the ETF market.
Source: ETF Trends
Market Sentiment:
Positive
AllianceBernstein Launches Five New Active ETFs
2 years ago
Quick Summary
AllianceBernstein Holding L.P. has introduced one Buffered product and four Fixed Income products in its ETF suite, enhancing its investment offerings.
Why It Matters
AllianceBernstein's introduction of new ETFs, including Buffered and Fixed Income products, signals potential growth in their offerings, impacting market competitiveness and investment strategies.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
EyeGate has incorporated Bayon Therapeutics' vision-restoring small molecules into its development pipeline, expanding its product offerings.
Why It Matters
EyeGate's acquisition of Bayon Therapeutics' small molecules enhances its pipeline, potentially leading to new treatments and revenue streams, impacting future valuations and market position.
Source: GlobeNewsWire
Market Sentiment:
Neutral
EYEG Stock Price: Why It Substantially Increased
4 years ago
Quick Summary
Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) saw a stock price increase of 22.95% in the last trading session.
Why It Matters
A 22.95% stock price increase signals strong investor interest and potential positive developments for Eyegate Pharmaceuticals, impacting future valuations and trading strategies.
Source: Pulse2
Market Sentiment:
Positive
Quick Summary
Seven penny stocks listed on Nasdaq are highlighted as potentially safer investments when adjusted for risk, suggesting their inclusion in diversified portfolios.
Why It Matters
The mention of Nasdaq-listed penny stocks suggests potential for growth with a safety net, attracting risk-tolerant investors seeking high-reward opportunities.
Source: InvestorPlace
Market Sentiment:
Positive
Frequently Asked Questions About EYEG Stock
What is AB Corporate Bond ETF's (EYEG) stock forecast for 2026?
Analyst forecasts for AB Corporate Bond ETF (EYEG) are not currently available. The stock is trading at $35.63.
Is EYEG stock a good investment in 2026?
According to current analyst ratings, EYEG has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $35.63. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for EYEG stock?
Price predictions from Wall Street analysts for EYEG are not currently available. The stock is trading at $35.63.
What is AB Corporate Bond ETF's business model?
The fund generates income and capital appreciation by investing at least 80% of its net assets in investment-grade corporate bonds. It employs a dynamic, multifactor investment strategy to achieve excess returns compared to its benchmark while managing risk.
What is the highest forecasted price for EYEG AB Corporate Bond ETF?
Price targets from Wall Street analysts for EYEG are not currently available. The stock is trading at $35.63.
What is the lowest forecasted price for EYEG AB Corporate Bond ETF?
Price targets from Wall Street analysts for EYEG are not currently available. The stock is trading at $35.63.
What is the overall EYEG consensus from analysts for AB Corporate Bond ETF?
The overall analyst consensus for EYEG is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are EYEG stock price projections?
Stock price projections, including those for AB Corporate Bond ETF, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 4:14 PM UTC